Skip to main content
About PeptideBase

Author

Alexandre Sherif Peterson

Founder, PeptideBase

01

About

Alexandre Sherif Peterson is the founder of PeptideBase, an independent provider directory and educational research platform for the peptide space. He built PeptideBase to bring structure and transparency to a fragmented market — systematically indexing 2,500+ providers, mapping 100+ peptides, and creating tools that help researchers find the right starting point.

PeptideBase is an independent project. All content is educational and informational — no medical advice framing, no dosing guidance, no clinical recommendations.

02

Articles

Providers

Is BPC-157 legal in the US?

BPC-157 isn't simply legal or illegal — the answer depends on which of two regulatory tracks your provider operates on. Here's how to tell.

Alexandre Sherif Peterson6 min
News

How the PeptideBase Matching Tool Works

PeptideBase's matching tool asks 7 questions about your goals and health background, then surfaces educational peptide and provider suggestions. Here's exactly how it works — and what the results actually mean.

Alexandre Sherif Peterson4 min
Providers

503A vs 503B Compounding Pharmacies: What's the Difference?

Not all compounding pharmacies are the same. 503A and 503B pharmacies operate under entirely different FDA frameworks — with different oversight, quality standards, and access rules. Here's what the distinction means for peptide therapy.

Alexandre Sherif Peterson5 min
Research

What Is TB-500 (Thymosin Beta-4)? Research, Effects & Providers

TB-500 is a synthetic peptide based on Thymosin Beta-4, a naturally occurring protein found in virtually every human cell. This guide covers the research, how it works, safety considerations, and how to find a verified provider.

Alexandre Sherif Peterson5 min
Research

PT-141 (Bremelanotide): What the Research Shows

PT-141 is a synthetic melanocortin receptor agonist studied for sexual dysfunction in both men and women. Unlike PDE5 inhibitors, it acts centrally through the nervous system rather than directly on vascular tissue.

Alexandre Sherif Peterson7 min
Research

NAD+: What the Research Shows About Cellular Energy and Longevity

NAD+ levels decline measurably with age. Here is what the published research says about IV and subcutaneous administration — and why functional medicine providers have made it a cornerstone of longevity protocols.

Alexandre Sherif Peterson6 min
Research

BPC-157: What the Research Shows About This Recovery Peptide

BPC-157 is among the most researched synthetic peptides in the recovery space. Here is what published animal studies show — and how to find licensed providers who include it in their protocols.

Alexandre Sherif Peterson5 min

Free newsletter

The Peptide Research Digest

Weekly analysis on providers, sourcing and compounds — from the team behind PeptideBase.

No spam. Unsubscribe anytime. Privacy policy.